Specifically, Tuo Deng et al. have demonstrated in HCC that endothelial progenitor cells release a higher quantity of CCL2, which stimulates the upregulation of CD36 and thus supports the pro-metastatic microenvironment [29]. The gene discussed is CCL2; the disease is hepatocellular carcinoma.